本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Atara Biotherapeutics

7.67
+0.42005.79%
盤後7.670.00000.00%17:56 EDT
成交量:13.81萬
成交額:111.11萬
市值:4,493.78萬
市盈率:-0.67
高:8.65
開:8.00
低:7.43
收:7.25
資料載入中...
2022/07/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/24

重要事件披露

8-K - Current report
2022/05/19

重要事件披露

8-K - Current report
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

重要事件披露

8-K - Current report
2022/04/04

重要事件披露

8-K - Current report
2022/03/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/28

重要事件披露

8-K - Current report
2022/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

重要事件披露

8-K - Current report
2022/01/10

重要事件披露

8-K - Current report
2022/01/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals